This hormonal interplay means that two patients using identical microdosing amounts may experience very different outcomes based on their unique hormonal profiles, underscoring the importance of individualized dosing and close monitoring
A dose-dependent inhibition of cytochrome P450, family 1, subfamily A, polypeptide 1 and cytochrome P450, family 2, subfamily B, polypeptide 1/2 by sulforaphane (SFN) was observed in rat hepatocytes, and also the expression of cytochrome P450, family 3, subfamily A, polypeptide 4 (the major cytochrome P450 enzyme in human liver) was markedly decreased at both mRNA and activity levels ( Reference Maheo, Morel and Langouet 17 )
Keep treated areas out of direct sunlight and avoid high temperature
P186 Does deprivation impact headache diagnosis and migraine management in England